Skip to main content
. Author manuscript; available in PMC: 2023 Sep 19.
Published in final edited form as: Vaccine. 2013 Jul 13;31(42):4917–4922. doi: 10.1016/j.vaccine.2013.07.015

Table 3.

Tetanus and diphtheria seroprevalence among participants tested for both antibodies.

Age groups Total tested for both antibodies, No. Seropositive for both
Tetanus-seropositive, Diphtheria-seronegative
Tetanus seronegative, diphtheria seropositive
Seronegative for both
No. % No. % No. % No. %

1–2 years 206 133 64.6 53 25.7 2 1.0 18 8.7
3–6 years 420 244 58.1 112 26.7 2 0.5 62 14.8
7–9 years 271 171 63.1 50 18.5 3 1.1 47 17.3
10–14 years 513 198 38.6 143 27.9 2 0.4 170 33.1
15–19 years 475 162 34.1 170 35.8 12 2.5 131 27.6
20–24 years 434 290 66.8 109 25.1 2 0.5 33 7.6
Total 2319 1198 51.7 637 27.4 23 1.0 461 19.9